Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream Aug 19, 2025 07:00AM
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream May 20, 2025 07:00AM
HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I. Sep 25, 2023 08:00AM
HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards Sep 11, 2023 04:15PM
HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference May 2, 2023 08:15AM


Apr 17, 2023 08:15AM HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023
Mar 16, 2023 04:15PM HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results
Feb 7, 2023 11:04AM HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time
Feb 6, 2023 07:30AM HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease
Feb 3, 2023 09:00AM Heart Test Laboratories (HSCS) Announces Further Internationalization of its Patent Portfolio
Feb 3, 2023 09:00AM HeartSciences Announces Further Internationalization of its Patent Portfolio
Jan 23, 2023 09:00AM Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th
Jan 20, 2023 09:00AM HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th
Jan 4, 2023 09:00AM HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive
Dec 16, 2022 08:30AM HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results
Dec 1, 2022 09:00AM HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms
Nov 28, 2022 09:00AM HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022
Nov 21, 2022 09:00AM HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022
Nov 10, 2022 09:00AM HeartSciences’ MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events
Oct 25, 2022 09:00AM HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG
Oct 20, 2022 09:00AM HeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine
Oct 18, 2022 09:00AM HeartSciences to Present at the LD Micro Main Event XV on October 26th